Cardlytics
CDLX
163 hedge funds and large institutions have $2.17B invested in Cardlytics in 2021 Q4 according to their latest regulatory filings, with 30 funds opening new positions, 67 increasing their positions, 37 reducing their positions, and 30 closing their positions.
81% more repeat investments, than reductions
Existing positions increased: 67 | Existing positions reduced: 37
0.42% more ownership
Funds ownership: 9.46% → 9.88% (+0.42%)
0% more funds holding in top 10
Funds holding in top 10: 9 → 9 (0)
0% more first-time investments, than exits
New positions opened: 30 | Existing positions closed: 30
1% less funds holding
Funds holding: 164 → 163 (-1)
17% less capital invested
Capital invested by funds: $2.62B → $2.17B (-$453M)
68% less call options, than puts
Call options by funds: $11.4M | Put options by funds: $35.9M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Ameriprise
Minneapolis,
Minnesota
|
+$37.2M |
| 2 |
Jennison Associates
New York
|
+$28.8M |
| 3 |
JP Morgan Chase
New York
|
+$17M |
| 4 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
+$13.2M |
| 5 |
BCM
Brightlight Capital Management
Westport,
Connecticut
|
+$11.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BNP Paribas Asset Management
Paris,
France
|
-$35.6M |
| 2 |
BCP
Berylson Capital Partners
Boston,
Massachusetts
|
-$8.66M |
| 3 |
SM
Selkirk Management
Chatham,
New Jersey
|
-$5.93M |
| 4 |
BlackRock
New York
|
-$5.73M |
| 5 |
UOC
UBS O'Connor
Chicago,
Illinois
|
-$5.46M |
CDLX Hedge Fund Activity: Q4 2021 in Review
163 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Cardlytics (CDLX) for Q4 2021, worth a combined $2.17B — down 17% from $2.62B a quarter earlier.
Fund positioning in CDLX was balanced in Q4 2021: 30 funds opened new positions, 30 closed out, 67 added to existing stakes and 37 trimmed.
The largest buyer was Ameriprise, adding an estimated $37.2M. The largest seller was BNP Paribas Asset Management, exiting entirely with an estimated $35.6M sold.
- 163 institutional investors held Cardlytics (CDLX) as of Q4 2021, down from 164 in Q3 2021.
- Funds reported $2.17B of Cardlytics stock for Q4 2021, down 17% quarter-over-quarter.
- 30 funds opened new Cardlytics positions in Q4 2021 and 30 closed out, a net change of 0 holders.
- The largest Cardlytics buyer in Q4 2021 was Ameriprise, an estimated $37.2M added.
- The largest Cardlytics seller in Q4 2021 was BNP Paribas Asset Management, an estimated $35.6M sold.
Based on aggregated 13F filings for Q4 2021.